Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment. [PDF]
Marchesi S +5 more
europepmc +1 more source
High expression of STAT3 and PD-L1 predicts poor prognosis for laryngeal squamous cell carcinoma. [PDF]
Shui T, Pan Y, Hong J.
europepmc +1 more source
A conditional multi-signal validation framework for cancer immunotherapy: the adaptive anti-error biological system. [PDF]
Kalondero EM.
europepmc +1 more source
Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy. [PDF]
Liu Q +8 more
europepmc +1 more source
Crosstalk between tumor-associated macrophages and the B7/CD28 family in immune checkpoint inhibitor-induced immunotherapy. [PDF]
Bai R, Sun W.
europepmc +1 more source
Discrepant CD3+ TILs in PD-L1-Negative NSCLC: Favorable Outcome in an Elderly Patient Treated With Nivolumab, Ipilimumab, and Chemotherapy. [PDF]
Sekiya M +4 more
europepmc +1 more source
Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab. [PDF]
Vanni I +13 more
europepmc +1 more source
Association Between Polymorphisms in Genes Encoding PD-1/PD-L1 Molecules and Clinicopathological Features in Clear Cell Renal Cell Carcinoma. [PDF]
Onyszczuk M +3 more
europepmc +1 more source
The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment. [PDF]
Papavassiliou KA +2 more
europepmc +1 more source

